Non-Invasive Prenatal Testing Market to Double by 2030: Growth at 10.08% CAGR

►Non-Invasive Prenatal Testing (NIPT) Market to Double by 2030 Driven by Technological Advancements & Rising Maternal Age

Non-Invasive Prenatal Testing (NIPT) Market Overview

According to Maximize Market Research, the Non-Invasive Prenatal Testing Market was valued at USD 5.12 Billion in 2023 and is projected to almost double, reaching nearly USD 10.03 Billion by 2030, growing at a CAGR of 10.08% from 2024 to 2030. The market expansion is fueled by increasing awareness, advanced genomics, and rising maternal age.

Competitive Landscape & High Demand Regions
The NIPT market is highly competitive, with major players like Illumina, Inc., F. Hoffmann-La Roche Ltd., Natera, Inc., Laboratory Corporation of America Holdings, and Yourgene Health actively innovating. Higher demand is notably observed in Asia-Pacific and North America, driven by healthcare investments, awareness campaigns, and policy support.

Curious to peek inside? Grab your sample copy of this report now:https://www.maximizemarketresearch.com/request-sample/32130/

►Vietnam - NIPT Market Growth & Consolidation

Vietnam is emerging as a promising market for NIPT, fueled by urbanization and rising healthcare expenditure. Recently, Gene Solutions Vietnam expanded its testing services, partnering with local clinics to make NIPT accessible nationwide.

Additionally, domestic consolidation efforts by private diagnostic labs are creating a competitive landscape aimed at increasing affordability and reliability.

►Thailand - NIPT Opportunity & Updation

Thailand's NIPT market is witnessing strong growth opportunities, driven by medical tourism and advanced lab infrastructure. Samitivej Hospital partnered with Yourgene Health to introduce faster and more affordable NIPT options.

In terms of updates, Thailand's government recently introduced guidelines to standardize prenatal screening, boosting market demand.

►Singapore - NIPT Trends & Consolidation

Singapore remains a technological leader in Southeast Asia's NIPT market. Key trend: integration of AI and data analytics into NIPT processes.

Recent consolidation includes Raffles Medical Group collaborating with Illumina, Inc. to enhance testing precision and offer personalized genetic counseling.

Eager to discover what's within? Secure your sample copy of the report today:https://www.maximizemarketresearch.com/request-sample/32130/

►Japan - NIPT Growth & Opportunity

Japan is experiencing significant growth due to its aging maternal population and robust insurance frameworks. Sysmex Corporation partnered with Riken Genesis to expand NIPT service reach beyond urban centers.

Opportunities also include next-generation sequencing (NGS) integration and cross-lab collaborations to lower costs.

►South Korea - NIPT Trends & Updation

In South Korea, trends highlight the preference for microdeletion and chromosomal anomaly panels. Recent updates include GC Labs partnering with Natera, Inc. to launch advanced cfDNA-based tests.

Additionally, the Korean government has expanded coverage for prenatal genetic testing, increasing market accessibility.

►United States - NIPT Market Opportunity & Consolidation

The U.S. leads global NIPT adoption, driven by innovation and policy changes. Illumina, Inc. recently launched new NIPT panels covering a broader range of anomalies.

Consolidation in the U.S. saw Labcorp acquiring smaller biotech firms to expand service coverage and enhance test accuracy.

►Europe - NIPT Market Trends & Recent Developments

Europe's NIPT market shows rising trends in non-invasive screening for single-gene disorders. Recent developments include F. Hoffmann-La Roche Ltd. collaborating with European clinics to improve data interoperability and reduce turnaround time.

Countries like Germany and France have introduced partial reimbursement policies, boosting adoption rates.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:https://www.maximizemarketresearch.com/request-sample/32130/

► Market Segmentation: In-Depth Analysis:

• By Gestation Period

0-12 Weeks
13-24 Weeks
25-36 Weeks

• By Pregnancy Risk

High & Average Risk
Low Risk

• By Method

Ultrasound Detection
Biochemical Screening Tests
Cell-free DNA in Maternal Plasma Tests

• By Technology

NGS
Array Technology
PCR
Others

• By Product

Consumables & Reagents
Instruments

• By Application

Trisomy
Microdeletion Syndrome
Other Applications

Because chromosomal disorders in prenatals are becoming more common, the Trisomy segment lead the global non-invasive prenatal testing market. Technological developments have expanded testing capabilities to include whole-genome sequencing, which enables the identification of many other chromosomal abnormalities, such as sex chromosome abnormalities and microdeletions. Nonetheless, during the projected period, the microdeletion syndrome segment is anticipated to develop rapidly. A number of factors, including the rising incidence of microdeletion syndromes, people's increased awareness of chromosomal abnormalities, and improvements in screening test technology, are responsible for this increase.

• By End-User

Hospitals
Diagnostic Laboratories
Others

In 2023, Diagnostic Laboratories dominated the global non-invasive prenatal testing market and had the greatest revenue share, at over 45%. Over the course of the forecast period, the segment is anticipated to continue its upward trajectory. A number of factors contribute to the growing need for such testing at these facilities, making diagnostic labs essential NIPT hubs. Diagnostic labs have the sophisticated technology infrastructure needed to carry out the complex genetic analysis necessary for NIPT. This is anticipated to be the primary driver of the segment's expansion.

For deeper market insights, peruse the summary of the research report:https://www.maximizemarketresearch.com/market-report/global-non-invasive-prenatal-testing-market/32130/

► Learn about the top players driving innovation in the Market :

• Leading Non-invasive prenatal testing services providers in the North America:
1. Laboratory Corporation of America Holdings (LabCorp) - (Carolina, USA)
2. Agilent Technologies, Inc. - (California, USA)
3. Thermo Fisher Scientific Inc. - (Massachusetts, USA)
4. GE Healthcare - (Chicago, Illinois, USA; part of General Electric Company)
5. Progenity, Inc. - (San Diego, California, USA)
6. Genesis Genetics (CooperSurgical, Inc.) - (Livingston, New Jersey, USA)
7. Natera, Inc. - (San Carlos, California, USA)
8. Illumina, Inc. (Verinata Health, Inc.) - (San Diego, California, USA)
9. Myriad Women's Health, Inc. (Counsyl, Inc.) - (South San Francisco, California, USA)
10. Quest Diagnostics, Inc. - (Secaucus, New Jersey, USA)

• Major non-prenatal testing solution providers in Europe:
1. Eurofins LifeCodexx AG - (Konstanz, Germany)
2. Yourgene Health - (Manchester, United Kingdom)
3. Centogene N.V. - (Rostock, Germany)
4. F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics) - (Basel, Switzerland)
5. IGENOMIX - (Valencia, Spain)
6. Qiagen - (Venlo, Netherlands)

• List of non-invasive prenatal testing services providers in Asia:
1. BGI (Beijing Genomics Institute) - (Shenzhen, China)
2. MedGenome Labs Ltd. - (Bangalore, India)
3. Eisai (Japan)
4. Nihon Gene Research Laboratories (NGRL) (Japan)
5. Seegene (South Korea)
6. Genetic Diagnostics Singapore (GDS) (Singapore)

► Get Market Research Latest Trends :

♦ Nitrile Gloves Market https://www.maximizemarketresearch.com/market-report/nitrile-gloves-market/126531/

♦ Global Laboratory Developed Testing Market https://www.maximizemarketresearch.com/market-report/global-laboratory-developed-testing-market/87457/

♦ Global Lancets Market https://www.maximizemarketresearch.com/market-report/global-lancets-market/31935/

♦ Parenteral Nutrition Market https://www.maximizemarketresearch.com/market-report/parenteral-nutrition-market/38008/

♦ Global Healthcare Cold Chain Logistics Market https://www.maximizemarketresearch.com/market-report/global-healthcare-cold-chain-logistics-market/83326/

♦ Global Marine Biotechnology Market https://www.maximizemarketresearch.com/market-report/global-marine-biotechnology-market/21939/

♦ global Ambulance Market https://www.maximizemarketresearch.com/market-report/global-ambulance-market/71359/

♦ Global Immune Health Supplements Market https://www.maximizemarketresearch.com/market-report/global-immune-health-supplements-market/26839/

♦ Anticancer Drugs Market https://www.maximizemarketresearch.com/market-report/anticancer-drugs-market/37133/

♦ Global Diabetes Foot Ulcers Treatment Market https://www.maximizemarketresearch.com/market-report/global-diabetes-foot-ulcers-treatment-market/98438/

♦ Wearable Medical Devices Market https://www.maximizemarketresearch.com/market-report/wearable-medical-devices-market/1358/

♦ global Flexible & SemiRigid Ureteroscopy Market https://www.maximizemarketresearch.com/market-report/global-flexible-semi-rigid-ureteroscopy-market/16687/

♦ Global Oxygen Concentrators Market https://www.maximizemarketresearch.com/market-report/global-oxygen-concentrators-market/9845/

♦ Global Packaging Tape Printing Market https://www.maximizemarketresearch.com/market-report/global-packaging-tape-printing-market/85245/

♦ Global Cold Laser Therapy Market https://www.maximizemarketresearch.com/market-report/global-cold-laser-therapy-market/54821/

► Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656

► About Maximize Market Research:

Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.

This release was published on openPR.